Literature DB >> 10227612

Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force.

R G Miller, J A Rosenberg, D F Gelinas, H Mitsumoto, D Newman, R Sufit, G D Borasio, W G Bradley, M B Bromberg, B R Brooks, E J Kasarskis, T L Munsat, E A Oppenheimer.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10227612     DOI： 10.1212/wnl.52.7.1311

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  61 in total

1.  Riluzole treatment in advanced ALS.

Authors:  Gian Domenico Borasio
Journal:  J Neurol       Date:  2002-05       Impact factor: 4.849

Review 2.  The management of motor neurone disease.

Authors:  P N Leigh; S Abrahams; A Al-Chalabi; M-A Ampong; L H Goldstein; J Johnson; R Lyall; J Moxham; N Mustfa; A Rio; C Shaw; E Willey
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

Review 3.  Management of motor neurone disease.

Authors:  R S Howard; R W Orrell
Journal:  Postgrad Med J       Date:  2002-12       Impact factor: 2.401

4.  Spinal muscular atrophy--type I.

Authors:  M K M Hardart; R D Truog
Journal:  Arch Dis Child       Date:  2003-10       Impact factor: 3.791

5.  Motor neuron disease: focusing the mind on ALS: updated practice parameters.

Authors:  P Nigel Leigh; Lokesh C Wijesekera
Journal:  Nat Rev Neurol       Date:  2010-04       Impact factor: 42.937

6.  Pseudobulbar affect (PBA) in an incident ALS cohort: results from the Apulia registry (SLAP).

Authors:  Rosanna Tortelli; Massimiliano Copetti; Simona Arcuti; Marianna Tursi; Annalisa Iurillo; Maria Rosaria Barulli; Rosa Cortese; Rosa Capozzo; Eustachio D'Errico; Benoit Marin; Isabella Laura Simone; Giancarlo Logroscino
Journal:  J Neurol       Date:  2015-11-20       Impact factor: 4.849

Review 7.  Advances in clinical trials for amyotrophic lateral sclerosis.

Authors:  Paul H Gordon
Journal:  Curr Neurol Neurosci Rep       Date:  2005-02       Impact factor: 5.081

8.  ALS multidisciplinary clinic and survival. Results from a population-based study in Southern Italy.

Authors:  Stefano Zoccolella; Ettore Beghi; Guerrino Palagano; Angela Fraddosio; Vito Guerra; Vito Lepore; Isabella Laura Simone; Paolo Lamberti; Luigi Serlenga; Giancarlo Logroscino
Journal:  J Neurol       Date:  2007-04-13       Impact factor: 4.849

9.  Predictors of emergent feeding tubes and tracheostomies in amyotrophic lateral sclerosis (ALS).

Authors:  Amy Y Tsou; Jason Karlawish; Leo McCluskey; Sharon X Xie; Judith A Long
Journal:  Amyotroph Lateral Scler       Date:  2012-05

10.  Melatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis.

Authors:  Yi Zhang; Anna Cook; Jinho Kim; Sergei V Baranov; Jiying Jiang; Karen Smith; Kerry Cormier; Erik Bennett; Robert P Browser; Arthur L Day; Diane L Carlisle; Robert J Ferrante; Xin Wang; Robert M Friedlander
Journal:  Neurobiol Dis       Date:  2013-03-26       Impact factor: 5.996
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.